Link to Pubmed [PMID] – 36369758
Link to DOI – 10.1080/13548506.2022.2144637
Psychol Health Med 2023 Apr; 28(4): 1076-1086
Meniere’s disease is an otological disease characterized by various symptoms that include episodic peripheral vertigo, sensorineural hearing loss, tinnitus, and aural fullness, all of which deteriorate the maintenance of daily activities. We aimed to investigate cognitive function in Meniere’s disease patients and compare their results to those of healthy controls. Eighteen patients diagnosed with definite Meniere’s disease without any psychiatric, neurological or otological comorbidity, and 30 healthy controls with normal cognitive functions were included in the study. General cognitive status, attention, verbal memory, visual memory, executive and visuospatial function were measured by detailed neuropsychological tests in both groups. In the patients with Meniere’s disease, pure-tone hearing thresholds, and speech discrimination scores were also measured. Patients with Meniere’s disease showed lower levels of performance in the trail making test, Oktem verbal memory processes, Rey Complex Figure Test, Wisconsin Card Sorting Test, semantic and phonemic fluency than did healthy controls. In other words, there were deficits in attention, recognition and recall in verbal memory, recall in visual memory, visual spatial construction, and planning skills in patients with Meniere’s disease. Education years and depression scores of participants had a significant effect on cognitive function in all groups. This study is an update and confirmation of the findings of studies showing cognitive impairment in patients with Meniere’s disease. In addition to previous findings, this study found a decrease in executive function performance in patients with Meniere’s disease compared to healthy controls. Unlike previous studies, this study comprehensively addressed all cognitive functions and included a control group. Our results emphasize that executive functions, which are high-level cognitive processes, may affect the compliance of patients with Meniere’s disease treatment and follow-up processes.